Tetraphase Pharmaceuticals, Inc. EPS - Earnings per Share 2013-2020 | TTPH
Tetraphase Pharmaceuticals, Inc. eps - earnings per share from 2013 to 2020. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Tetraphase Pharmaceuticals, Inc. Annual EPS |
| 2019 |
$-22.85 |
| 2018 |
$-27.48 |
| 2017 |
$-52.60 |
| 2016 |
$-42.20 |
| 2015 |
$-47.20 |
| 2014 |
$-49.80 |
| 2013 |
$-35.60 |
| 2012 |
$-950.80 |
| 2011 |
$-1,466.80 |
| Tetraphase Pharmaceuticals, Inc. Quarterly EPS |
| 2020-03-31 |
$-1.31 |
| 2019-12-31 |
$-1.20 |
| 2019-09-30 |
$-6.00 |
| 2019-06-30 |
$-8.40 |
| 2019-03-31 |
$-7.25 |
| 2018-12-31 |
$-8.09 |
| 2018-09-30 |
$-7.39 |
| 2018-06-30 |
$-3.60 |
| 2018-03-31 |
$-8.40 |
| 2017-12-31 |
$-7.60 |
| 2017-09-30 |
$-12.60 |
| 2017-06-30 |
$-16.60 |
| 2017-03-31 |
$-15.80 |
| 2016-12-31 |
$-12.00 |
| 2016-09-30 |
$-11.60 |
| 2016-06-30 |
$-9.40 |
| 2016-03-31 |
$-9.20 |
| 2015-12-31 |
$-9.80 |
| 2015-09-30 |
$-9.80 |
| 2015-06-30 |
$-14.40 |
| 2015-03-31 |
$-13.20 |
| 2014-12-31 |
$-14.00 |
| 2014-09-30 |
$-11.00 |
| 2014-06-30 |
$-14.20 |
| 2014-03-31 |
$-10.60 |
| 2013-12-31 |
$9.60 |
| 2013-09-30 |
$-9.80 |
| 2013-06-30 |
$-5.20 |
| 2013-03-31 |
$-30.20 |
| 2012-12-31 |
$-479.40 |
| 2012-09-30 |
$-192.60 |
| 2012-06-30 |
$-268.40 |
| 2012-03-31 |
$-10.40 |
